Document is current
Any future updates will be listed below
-
Authors
,
Hammond, Edward R.
Crum, Rosa M.
Treisman, Glenn J.
Mehta, Shruti H.
Clifford, David B.
Ellis, Ronald J.
Gelman, Benjamin B.
Grant, Igor
Letendre, Scott L.
Marra, Christina M.
Morgello, Susan
Simpson, David M.
Mcarthur, Justin C.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R03 MH095640-02)
National Institutes of Health (N01 MH22005, HHSN271201000027C, and HHSN271201000030C)
- License Information
-
More Information
Article History
Received: 25 July 2015
Revised: 4 December 2015
Accepted: 9 December 2015
First Online: 4 January 2016
Compliance with ethical standards
: The study was approved by the Institutional Review Board (IRB) or Western IRB for each study site and each participant provided written informed consent.
: The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) is supported by the awards N01 MH22005, HHSN271201000027C, and HHSN271201000030C from the National Institutes of Health. The current analyses were funded by R03 MH095640-02 from the National Institutes of Mental Health. The study sponsor had no role in the design, analyses, interpretation, or reporting of the study.
: Rosa M. Crum declares no conflict of interest. Ronald J. Ellis declares no conflict of interest. Igor Grant declares no conflict of interest. Benjamin B. Gelman declares no conflict of interest. Edward R. Hammond declares no conflict of interest. Justin C. McArthur declares no conflict of interest. David B. Clifford has been a Consultant to Biogen Idec, M.illennium, Bristol Myers Squibb, Pfizer, Genzyme, Amgen, Quintiles, and Sun Biopharma. Scott L. Letendre has research grants/grants pending from Abbvie, GlaxoSmithKline, and Merck. Christina M. Marra has received payment for lectures from universities and societies, and royalties from LLW, UpToDate. Shruti H. Mehta has received payment for lectures at a university. Susan Morgello has lectured for Health Clear Strategies. David M. Simpson has been a Consultant for Astellas, Merz, Ipsen, Acorda Therapeutics, Depomed, Syntaxin, Viromed, Biogen, and Allergan. Glenn J. Treisman has received payment for lectures from universities.
